SEC Form 4 · accession 0001645627-18-000071
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Nov 7, 2018
Accepted (ET)
Nov 13, 2018 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2018 | P | 1,000 | $0.038 | A | 26,133,498 | D | |
| Common Stock | Nov 7, 2018 | P | 2,000 | $0.0386 | A | 26,135,498 | D | |
| Common Stock | Nov 7, 2018 | P | 1,000 | $0.0387 | A | 26,136,498 | D | |
| Common Stock | Nov 7, 2018 | P | 1,000 | $0.0386 | A | 26,137,498 | D | |
| Common Stock | Nov 8, 2018 | P | 1,000 | $0.0385 | A | 26,138,498 | D | |
| Common Stock | Nov 9, 2018 | P | 2,000 | $0.0399 | A | 26,140,498 | D | |
| Common Stock | Nov 9, 2018 | P | 2,000 | $0.04 | A | 26,142,498 | D | |
| Common Stock | Nov 12, 2018 | P | 1,000 | $0.0392 | A | 26,143,498 | D | |
| Common Stock | Nov 12, 2018 | P | 1,000 | $0.0412 | A | 26,144,498 | D | |
| Common Stock | Nov 12, 2018 | P | 1,000 | $0.0396 | A | 26,145,498 | D | |
| Common Stock | Nov 12, 2018 | P | 1,000 | $0.0385 | A | 26,146,498 | D | |
| Common Stock | Nov 13, 2018 | P | 1,000 | $0.0392 | A | 26,147,498 | D |
Table II — derivative securities
No Table II lines on this filing.